These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 20398902

  • 1. Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption.
    Corella D, Carrasco P, Amiano P, Arriola L, Chirlaque MD, Huerta JM, Martínez C, Martinez-Camblor P, Molina E, Navarro C, Quirós JR, Rodríguez L, Sánchez MJ, Ortega-Azorín C, Ros E, Sala N, González CA, Moreno C.
    Atherosclerosis; 2010 Aug; 211(2):531-8. PubMed ID: 20398902
    [Abstract] [Full Text] [Related]

  • 2. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME, O'Connor JJ, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1148-54. PubMed ID: 12117730
    [Abstract] [Full Text] [Related]

  • 3. CETP TaqIB genotype modifies the association between alcohol and coronary heart disease: the INTERGENE case-control study.
    Mehlig K, Strandhagen E, Svensson PA, Rosengren A, Torén K, Thelle DS, Lissner L.
    Alcohol; 2014 Nov 01; 48(7):695-700. PubMed ID: 25288221
    [Abstract] [Full Text] [Related]

  • 4. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2000 May 01; 20(5):1323-9. PubMed ID: 10807749
    [Abstract] [Full Text] [Related]

  • 5. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
    Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP, Douville P, Bergeron J.
    Nephron; 2000 Apr 01; 84(4):333-41. PubMed ID: 10754410
    [Abstract] [Full Text] [Related]

  • 6. Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population.
    Padmaja N, Kumar RM, Balachander J, Adithan C.
    Clin Chim Acta; 2009 Apr 01; 402(1-2):139-45. PubMed ID: 19168039
    [Abstract] [Full Text] [Related]

  • 7. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U, Williamson DW, Huang Y, Mahley RW.
    Clin Genet; 2005 Aug 01; 68(2):118-27. PubMed ID: 15996208
    [Abstract] [Full Text] [Related]

  • 8. Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women.
    Jensen MK, Mukamal KJ, Overvad K, Rimm EB.
    Eur Heart J; 2008 Jan 01; 29(1):104-12. PubMed ID: 18063597
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM.
    Atherosclerosis; 2002 Apr 01; 161(2):469-74. PubMed ID: 11888533
    [Abstract] [Full Text] [Related]

  • 10. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.
    Dullaart RP, Sluiter WJ.
    Pharmacogenomics; 2008 Jun 01; 9(6):747-63. PubMed ID: 18518852
    [Abstract] [Full Text] [Related]

  • 11. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ, Zhang SZ, He Y, Zhang L, Zhang KL, Huang DJ, Sun Y.
    Chin Med J (Engl); 2004 Sep 01; 117(9):1288-92. PubMed ID: 15377415
    [Abstract] [Full Text] [Related]

  • 12. Interactions between alcohol intake and the polymorphism of rs708272 on serum high-density lipoprotein cholesterol levels in the Guangxi Hei Yi Zhuang population.
    Zhou Y, Yin R, Deng Y, Li Y, Wu J.
    Alcohol; 2008 Nov 01; 42(7):583-91. PubMed ID: 18835593
    [Abstract] [Full Text] [Related]

  • 13. The CETP TaqIB polymorphism is associated with the risk of sudden death in type 2 diabetic patients.
    Porchay-Baldérelli I, Péan F, Bellili N, Jaziri R, Marre M, Fumeron F, DIABHYCAR Study Group.
    Diabetes Care; 2007 Nov 01; 30(11):2863-7. PubMed ID: 17666459
    [Abstract] [Full Text] [Related]

  • 14. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P, Mensink RP, Hornstra G.
    Nutr Metab Cardiovasc Dis; 2002 Dec 01; 12(6):317-24. PubMed ID: 12669678
    [Abstract] [Full Text] [Related]

  • 15. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R, Galvan G, Malaimare L, Derflinger I, Hedegger M, Lang J, Iglseder B, Ladurner G, Paulweber B.
    Biomed Pharmacother; 2004 Dec 01; 58(10):619-27. PubMed ID: 15589073
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between cholesteryl ester transfer protein gene -629C→A mutations with HDL-C levels and coronary heart disease].
    Gao J, Mao YM, Cong HL, Liu Y, Zhang N, Chen Q, Liu T, Cui RZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May 01; 41(5):399-405. PubMed ID: 24021123
    [Abstract] [Full Text] [Related]

  • 17. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ.
    Circulation; 2005 Jan 25; 111(3):278-87. PubMed ID: 15655129
    [Abstract] [Full Text] [Related]

  • 18. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec 25; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 19. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
    Kaman D, İlhan N, İlhan N, Akbulut M.
    Bosn J Basic Med Sci; 2015 Feb 01; 15(1):9-13. PubMed ID: 25725138
    [Abstract] [Full Text] [Related]

  • 20. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians.
    Cuchel M, Wolfe ML, deLemos AS, Rader DJ.
    Atherosclerosis; 2002 Jul 01; 163(1):169-74. PubMed ID: 12048136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.